Publication: Percutanous management of tricuspid regurgitation: the "Achilles tendon" of transcatheter valve interventions
Program
KU-Authors
KU Authors
Co-Authors
Marmagkiolis, Konstantinos
Editor & Affiliation
Compiler & Affiliation
Translator
Other Contributor
Date
Language
Type
Embargo Status
N/A
Journal Title
Journal ISSN
Volume Title
Alternative Title
Abstract
Moderate-to-severe tricuspid insufficiency affects 1.6 million patients in the USA, resulting in increased morbidity and mortality and without safe and effective medical or surgical treatment options. The unique tricuspid valve anatomy, the presence of immediate adjacent anatomic landmarks at risk and the decreased blood pressure of flow complicate the development of effective transcatheter strategies. The HOVER trial will assess the safety and effectiveness of the CAVI approach with implantation of the Edwards, Sapien XT in the inferior vena cava.
Source
Publisher
Wiley
Subject
Interventional cardiology
, Structural heart disease
, Tricuspid valve disease
Citation
Has Part
Source
Catheterization and Cardiovascular Interventions
Book Series Title
Edition
DOI
10.1002/ccd.26665
item.page.datauri
Link
Rights
N/A